UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes

Diabetes therapy, 2019-02, Vol.10 (1), p.5-19

2019

Volltextzugriff (PDF)

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review

Diabetes therapy, 2019-04, Vol.10 (2), p.375-392

2019

Volltextzugriff (PDF)

Health-related quality of life in type 1 diabetes mellitus pediatric patients and their caregivers in Spain: an observational cross-sectional study

Current medical research and opinion, 2019-09, Vol.35 (9), p.1589-1595

2019

Volltextzugriff (PDF)

Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain

Current medical research and opinion, 2020-09, Vol.36 (9), p.1449-1456

2020

Volltextzugriff (PDF)

Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c

Journal of diabetes and its complications, 2020-07, Vol.34 (7), p.107575-107575, Article 107575

2020

Volltextzugriff (PDF)

Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort

Diabetes therapy, 2019-02, Vol.10 (1), p.57-69

2019

Volltextzugriff (PDF)

Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study

BMC public health, 2016-04, Vol.16 (296), p.248-248, Article 248

2016

Volltextzugriff (PDF)

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

Acta diabetologica, 2010-12, Vol.47 (Suppl 1), p.169-175

2010

Volltextzugriff (PDF)

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain

Applied health economics and health policy, 2012-11, Vol.10 (6), p.417

2012

Volltextzugriff (PDF)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions

Diabetes, metabolic syndrome and obesity, 2010-12, Vol.4 (default), p.1-4

2010

Volltextzugriff (PDF)

Social Economic Costs of Type 1 Diabetes Mellitus in Pediatric patients in Spain: CHRYSTAL Observational Study

Diabetes research and clinical practice, 2017-05, Vol.127, p.59-69

2017

Volltextzugriff (PDF)

Clinical evaluation of combined therapy for type 2 diabetes

Current medical research and opinion, 2010-05, Vol.26 (5), p.1171-1183

2010

Volltextzugriff (PDF)

Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study

Diabetes therapy, 2020-02, Vol.11 (2), p.437-451

2020

Volltextzugriff (PDF)

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study

Advances in therapy, 2021-07, Vol.38 (7), p.3857-3871

2021

Volltextzugriff (PDF)

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study

Applied health economics and health policy, 2012, Vol.10 (6), p.417-430

2012

Volltextzugriff (PDF)

Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens

Journal of clinical pharmacology, 2017-09, Vol.57 (9), p.1126-1137

2017

Volltextzugriff (PDF)

Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus

Medicina clínica, 2008-11, Vol.131 (19), p.721-730

2008

Volltextzugriff (PDF)

Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers

Endocrinología, diabetes y nutrición, 2021-10, Vol.68 (8), p.557-566

2021

Volltextzugriff (PDF)

Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens: Journal of Clinical Pharmacology

Journal of clinical pharmacology, 2017-09, Vol.57 (9), p.1126-1137

2017

Volltextzugriff (PDF)

Toward Better Understanding of Insulin Therapy by Translation of a PK‐PD Model to Visualize Insulin and Glucose Action Profiles

Journal of clinical pharmacology, 2019-02, Vol.59 (2), p.258-270

2019

Volltextzugriff (PDF)

Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage

BMC cardiovascular disorders, 2014-11, Vol.14 (1), p.153-153, Article 153

2014

Volltextzugriff (PDF)

Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature review

Endocrinología, diabetes y nutrición., 2019-04, Vol.66 (4), p.254-270

2019

Volltextzugriff (PDF)

Impact of frailty in older patients with diabetes mellitus: An overview

Endocrinologia y nutricion, 2016-06, Vol.63 (6), p.291-303

2016

Volltextzugriff (PDF)

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Current medical research and opinion, 2018-02, Vol.34 (2), p.329-336

2018

Volltextzugriff (PDF)

Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature review

Endocrinologia, diabetes y nutricion, 2019-04, Vol.66 (4), p.254-270

2019

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(50)
Humans
(36)
Female
(30)
Male
(27)
Endocrinology & Metabolism
(26)
Spain
(25)
Middle Aged
(18)
Adult
(17)
Diabetes
(17)
Aged
(13)
Biological And Medical Sciences
(11)
Diabetes Mellitus, Type 2 - Drug Therapy
(11)
Pharmacology & Pharmacy
(11)
Type 2 Diabetes
(11)
Type 2 Diabetes Mellitus
(11)
Endocrinology And Metabolism
(10)
Hypoglycemic Agents - Therapeutic Use
(10)
España
(9)
Insulin
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review

Health-related quality of life in type 1 diabetes mellitus pediatric patients and their caregivers in Spain: an observational cross-sectional study

Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain

Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c

Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort

Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions

Social Economic Costs of Type 1 Diabetes Mellitus in Pediatric patients in Spain: CHRYSTAL Observational Study

Clinical evaluation of combined therapy for type 2 diabetes

Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study

Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens

Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus

Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers

Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens: Journal of Clinical Pharmacology

Toward Better Understanding of Insulin Therapy by Translation of a PK‐PD Model to Visualize Insulin and Glucose Action Profiles

Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage

Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature review

Impact of frailty in older patients with diabetes mellitus: An overview

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature review

Suchergebnisse filtern